Colgate-Palmolive (NYSE:CL) Shares Sold by Prio Wealth Limited Partnership

Prio Wealth Limited Partnership trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 378,356 shares of the company’s stock after selling 3,686 shares during the period. Colgate-Palmolive accounts for 1.2% of Prio Wealth Limited Partnership’s portfolio, making the stock its 25th biggest position. Prio Wealth Limited Partnership’s holdings in Colgate-Palmolive were worth $39,277,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $25,000. Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the period. Register Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at about $48,000. Gradient Investments LLC boosted its stake in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after purchasing an additional 400 shares during the period. Finally, Financial Connections Group Inc. acquired a new position in Colgate-Palmolive during the 2nd quarter valued at about $68,000. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CL has been the subject of a number of analyst reports. UBS Group boosted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Bank of America boosted their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Stifel Nicolaus boosted their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $106.00.

Insiders Place Their Bets

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 over the last ninety days. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.9 %

CL traded down $0.95 on Monday, reaching $99.51. 445,774 shares of the company traded hands, compared to its average volume of 4,321,370. The stock’s 50 day moving average price is $103.43 and its 200-day moving average price is $97.66. Colgate-Palmolive has a 52-week low of $71.46 and a 52-week high of $109.30. The company has a market cap of $81.64 billion, a price-to-earnings ratio of 31.79, a PEG ratio of 3.54 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.77 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.